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ABSTRACT 
Background 
Obesity levels in the UK have reached a sustained high and about 5% of the population 
would be candidates for bariatric surgery based upon current UK NICE guidelines, which has 
important implications for Clinical Commissioning Groups. 
Sources of data 
Summary data from Cochrane systematic reviews, randomised controlled trials (RCTs) and 
cohort studies. 
Areas of agreement 
Currently the only treatment that offers significant and durable weight-loss for those with 
severe and complex obesity is surgery. Three operations account for 95% of all bariatric 
surgery in the UK, but the NHS offers surgery to only a small fraction of those who could 
benefit. Laparoscopic adjustable gastric banding (gastric banding) has potentially the lowest 
risk and up-front costs of the three procedures. 
Areas of controversy 
Reliable level 1 evidence of the relative effectiveness of the operations is lacking. 
Growing points 
As a point intervention, weight-loss surgery together with the chronic disease management 
strategy for obesity can prevent significant future disease and mortality, and the NHS should 
embrace both. 
Areas timely for developing research 
Better RCT evidence is needed including clinical effectiveness and economic analysis to 
answer the important question ‘which is the best of the three operations most frequently 
Page 3 of 43
http://mc.manuscriptcentral.com/bmb
Manuscripts submitted to British Medical Bulletin
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
4 
performed?’  This review considers the current evidence for gastric banding for the treatment 
of severe and complex obesity. 
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5 
INTRODUCTION 
Obesity is a major worldwide public health problem with significant implications for primary 
care, particularly where obesity prevalence in developed countries is as high as 32.5% in 
women in high income North American countries, 29.8% in Australasia and 21.0% in 
Western Europe [1]. Although obesity levels may have reached a plateau, the burden of the 
important obesity related co-morbidities, such as type 2 diabetes, which was 382 million 
people worldwide in 2013, is predicted to rise to over 590 million in 2035 [2]. Both diabetes 
and obesity are independent risk factors for many important cancers [3, 4].  Obesity 
significantly increases many functional disorders and worsens overall health related quality 
of life [5], which can be improved by weight loss and metabolic surgery [6]. Overall, there is 
substantial evidence that obesity is a chronic disease that shortens life expectancy, even 
with the current best medical management of its co-morbidities [7]. 
Bariatric surgery is the only reproducibly effective treatment for severe and complex obesity 
[8, 9]. UK NICE guidelines provide clear guidance for the delivery of health-care and 
recommend that: bariatric surgery is the first line of treatment for those with a BMI of ≥50 in 
whom lifestyle interventions have failed; and those with a BMI ≥40, or ≥35 with severe 
obesity-related co-morbidities, should be offered bariatric surgery [10]. Weight-loss and 
metabolic surgery procedures are among the most commonly performed elective general 
surgical operations in the world, with over 350,000 performed in 2011, [11] but in 2013 in the 
UK, with government funded health care, only around 8,000 operations were performed [12, 
13], of which around 4,300 operations are recorded as being performed in the public sector 
[14]. 
Bariatric surgery is a young surgical speciality, with increasing numbers of cases being 
performed over a relatively short time frame [11], and there is a lack of high quality long term 
outcome data for the procedures. The most up-to-date, 2014, Cochrane collaboration 
systematic review of weight loss surgery in adults could only provide synthesizable evidence 
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6 
for 3 years of follow up, and commented that ‘the long-term effects of surgery remain 
unclear’ [8]. However this level 1 evidence for short and medium term results of surgery can 
be compared directly to results for non-surgical interventions, and combined with some long-
term cohort studies of bariatric surgery, albeit in smaller numbers, to show a pattern of long-
term benefits from surgery. Given the established long-term benefit it is important to have 
large scale, pragmatic randomised controlled surgical trials to evaluate different techniques, 
to include economic evaluations, to give us the answer as to what is the best operation [15]. 
Gastric banding and how it facilitates weight loss 
In the UK >99% of gastric band procedures are performed laparoscopically and patients 
typically spend ≤1 days in hospital with very few early complications [12, 13]. The operation 
induces and sustains weight loss by activating a satiety mechanism., by aAdding or 
removing fluid from the band to achieves optimal filling. Food is not retained above the 
optimally adjusted band, i.e. not physically restricted, but briefly delayed food bolus transit 
through the band and the continuous pressure of the optimally filled band on the stomach 
wall produces both early satiety and a lack of appetite [16]. The effects of the band on 
oesophageal and proximal gastric function appears to activate a satiety signal, transmitted to 
CNS satiety centres via the vagus nerve, without physically restricting the meal size [16]. Figure 
1 shows the position of an gastric band with a small “virtual” pouch of stomach below the 
gastro-oesophageal junction, above the final band position, held within gastro-gastro 
tunnelling sutures. Ideally patients are followed up every 1 – 3 months for the first two years 
by the bariatric multidisciplinary team (MDT), and then yearly in conjunction with GPs as part 
of a shared care model of chronic disease management (NICE CG189) [10].  
Patients require life-long follow up for optimal weight control and co-morbidity resolution for 
gastric banding to work, especially as nutritional issues or complications can occur at any 
point after surgery [17, 18]. Symptoms of reflux, regurgitation or vomiting and especially 
nocturnal aspiration or dysphagia should alert the primary care GP to possible 
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7 
complications. Abdominal pain along with any of these symptoms may suggest an acute 
complication, but other causes of abdominal pain should always be considered. Lifelong 
care involves essential counselling about food choices and eating patterns, as well as 
adjustment of the band [18]. Patients should therefore not be offered revisional surgery 
unless a process for continuing care is in place with the bariatric multidisciplinary team and 
within primary care.  
 
Figure 1 The adjustable gastric band. (Images reproduced from SM Griffin, SA Raimes, J 
Shenfine. Oesophagogastric Surgery. 5th ed. Saunders Elsevier, 2013) 
 
Weight loss effects of gastric bands & bariatric surgery 
The 2014 Cochrane review into weight loss surgery for adults included 22 randomised trials 
with 1,798 participants. The authors compared surgery with non-surgical interventions or 
different surgical procedures and most studies followed participants for only 12 to 36 months 
[8]. All of the trials which compared surgery with non-surgical interventions for weight loss 
found that surgery was significantly superior for weight loss at 1-2 years. This mirrored a 
2013 systematic review and meta-analysis that directly compared surgery and medical 
therapy, using 11 randomised studies with 796 included patients, and a random effect 
model, clearly favouring surgery [9]. With study follow up of up to 2 years individuals 
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8 
undergoing bariatric surgery lost more body weight (mean difference −26 kg (95% 
confidence interval −31 to −21), P<0.001) than those with medical therapy alone. 
In the Cochrane review no clinically significant differences between the three main 
techniques of gastric band, all types of gastric bypass or sleeve gastrectomy existed for the 
majority of time points within ‘multi-trial’ evidence. Although only three trials directly 
compared gastric banding with laparoscopic Roux-en-Y gastric bypass (gastric bypass), the 
latter produced greater weight loss, with a mean difference in body mass index (BMI) 
reduction up to five years of -5.2 kg/m² (95% confidence interval -6.4 to -4.0; P<0.00001). 
However, this was only from a total of 265 patients when combined, and the quality of the 
evidence was described as moderate at best. In the seven included trials of gastric bypass 
and sleeve gastrectomy there was no consistent picture as to which procedure was better or 
worse, but with a low quality of evid nce [8]. For the 2013 systematic review the cumulative 
body weight loss was similar but not statistically significantly different between gastric 
banding and gastric bypass or other techniques combined (mean difference between 6 and 
7 kg, P>0.20) [9]. Effects on co-morbidities, complications and additional surgical procedures 
were neutral for the three main procedures in these reviews [8, 9]. Similarly a large 
prospective database, the Michigan Bariatric Surgery Collaborative, concluded that there 
was comparable effectiveness of gastric banding, gastric bypass and sleeve gastrectomy for 
the treatment of severe obesity, when assessing weight-loss and complications in 3 matched 
groups of nearly 3,000 patients each over 3 years [19]. 
As the low quality of evidence in data synthesis studies is a recurrent issue, there still exists 
a need for long-term data from a well-conducted, methodologically sound, pragmatic, 
multicentre, randomised trial of gastric banding and other bariatric techniques.  Two on-
going trials surgical randomised trials are the Swiss Multi-centre Bypass or Sleeve Study 
[20] and the UK By-Band randomised controlled trial [15].  In 2015 the latter has been 
converted to a three-arm trial of gastric banding, gastric bypass and sleeve gastrectomy (By-
Band-Sleeve), and is the only such trial in the world comparing all three techniques. 
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9 
Importantly these trials both include outcomes of weight and quality of life as primary 
outcome measures, and will also provide secondary outcome data on weight related co-
morbidities and an economic evaluation of the study groups. 
Longer-term weight loss outcomes for gastric banding  
In the absence of well-conducted randomised trials with funded long-term data collection, 
long-term data of bariatric surgery are only available from observational studies and a few 
small, randomised trials. Most individual studies that quote >10 year data report that 
obstacles to follow-up impede the collection of accurate long-term data [21]. The longest 
follow up data is from the Swedish Obesity Study (SOS) [22], and has shown that bariatric 
surgery can reduce mortality, as well as cardiovascular and cancer risk over more than 10 
years, in matched groups of over 2,000 patients. While two thirds of the patients in the SOS 
studies had a procedure that is no longer considered first line for weight loss (vertical 
banded gastroplasty), the study includes gastric bands with the longest follow up data being 
up to 20 years. The SOS shows maintenance of weight loss (18% of total body weight) in the 
all surgery groups at this time point, compared to 1% weight loss in controls, with 
sustainable reduction in diabetes rates, cardiovascular and cancer risks [23]. 
The only randomised trial with long term results of 10 years compared a small cohort (n = 
51) of Italian patients randomised to gastric banding or gastric bypass [24]. The mean 
percent excess weight loss achieved at 10 years was 46 % ± 27 for gastric banding vs 69 % 
± 29 for gastric bypass. With a mean BMI of patients in the two groups of 44, this equals a 
total body weight loss of 19 - 27%, comparable to that seen in the SOS study. A larger (n = 
197) US randomised trial with 4 year follow up to 2007 measured similar excess weight loss 
outcomes with 45 ± 28% for gastric band vs 68 ± 19% for bypass in the medium-term but 
bypass was associated with more peri-operative and late complications and a higher early 
readmission rate [25]. A systematic review of randomised and prospective studies 
comparing gastric banding with gastric bypass, with more than 3-5 year follow up (29 studies 
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10
with 7971 patients), similarly showed that the mean sample size–weighted percentage of 
excess weight loss for gastric banding was 45.0% (n = 4109) vs 65.7% for gastric bypass (n 
= 3544) [26]. In all of these studies gastric band patients had a slower initial weight loss, 
which was typically maintained in the medium to long-term. In contrast, bypass patients lost 
weight rapidly in the first year and then started to regain some weight [23-26]. Additionally 
with gastric banding there is a proportion of patients, up to 15% who do not tolerate the band 
and fail to achieve any meaningful weight loss [27]. 
Gastric banding is the most predominant technique in Australia, and from there O’Brien et al 
have reported on 15-year follow up data from a large prospectively followed cohort of over 
3,200 patients. The reported mean percent excess weight loss data is similar, 47% at 10 
years (n = 714), and at 15 years (although in only 54 patients) [287]. This again equals 
20.2% total body weight loss maintained at 10 - 15 years in the study population.   
Other long-term studies are ongoing, such as the US Longitudinal Assessment of Bariatric 
Surgery [289], which is prospectively following nearly 2,500 patients after weight loss 
surgery, one quarter of whom had a gastric band. Three-year results published so far 
suggest average weight loss of 16% total body weight for those undergoing a gastric band, 
with most of the weight loss coming in the first year for all patients. However compared to 
gastric bypass patients (who started to regain some weight) the trajectory of weight change 
in the gastric banding group was maintained. In summary, all of the studies with at least 10 
year follow up suggest that a clinically significant total body weight loss of 16 – 20 % is 
maintained in the long term following bariatric surgery, including gastric banding. 
Diabetic outcomes with gastric banding 
Diabetes patients are an important group of those undergoing bariatric surgery, accounting 
for nearly one third of UK NHS bariatric patients [12, 13], and they have potentially the 
greatest benefits with a reduction in long-term diabetic complications.  Early studies into 
bariatric surgery suggested that four fifths of all diabetic bariatric patients had a ‘resolution’ 
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11
of diabetes at 2 years following surgery [2930]. However a 2014 meta-analysis of longer 
term effects of metabolic surgery for type 2 diabetes, with stricter definitions for remission, 
reported a 65% remission rate and 89% remission or improvement rate in studies with more 
than 2 years follow up [3031]. The large UK national registry of bariatric surgery showed a 
60 – 70% improvement in all diabetic patients at 3 years following surgery, with a decrease 
in medication use [12, 13]. 
A systematic review in 2012 of 35 studies involving gastric banding to treat diabetes showed 
remission or improvement in diabetes from 53% to 70% over 2 years, and although there 
was considerable heterogeneity in study quality the authors concluded that clinically relevant 
improvements in diabetes outcomes occurred in obese people with type 2 diabetes following 
LAGB surgery [3132]. The only randomised trial included in this review by Dixon et al, 
consldered that participants randomized to surgical therapy were more likely to achieve 
remission of type 2 diabetes through greater weight loss [33]. The 2014 systematic review of 
studies comparing gastric banding with gastric bypass, included nine studies which 
measured co-morbidity improvement, and for type 2 diabetes (glycated haemoglobin <6.5% 
without medication), sample-size–weighted remission rates were 28.6% for gastric band (n = 
96) and 66.7% for gastric bypass (n = 428) [26].  
The interim analysis to assess the early control of type 2 diabetes (T2D), 1 year after gastric 
banding in the 5-year, prospective, observational Helping Evaluate Reduction in Obesity 
(HERO) study (N = 1,106) showed 72% achieved target control of diabetes compared with 
42% at baseline [3234]. It is important to note that in these band studies, and many other 
studies of bariatric surgery, patients with shorter disease duration and not yet on insulin have 
the best likelihood of control of diabetes [12, 24, 30 31- 3234]. Others have even performed 
studies of gastric banding in patients with lower BMIs and shown that remission of diabetes 
can be achieved in 50% of patients [3335]. Reflecting similar studies of all bariatric surgery 
in diabetics the 2014 UK NICE guidelines reduced the BMI threshold to 30 for ‘newly 
diagnosed diabetics’ to access bariatric surgery [10]. 
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Bariatric surgery can also aid diabetes prevention. In an analysis of SOS patients without 
diabetes (n = 3,429) and a BMI of 34 – 38 at the start, after 15 years the incident rates of 
diabetes was 28.4 per 1,000 in the controls but only 6.8 per 1,000 in those who had surgery 
[3436]. 
Complication rates  
The major complications of gastric banding requiring re-operation or removal, are infection of 
the band, slippage and erosion, plus a group of patients who have intolerance of the band 
and fail to achieve any meaningful weight loss. For complications, the large systematic 
reviews of weight-loss surgery report reoperation rates as high as 40% [8, 9], but this 
includes some very early studies. Indeed, studies of bands placed pre-2000 reported rates of 
reoperation or removal as high as 60% [3537], and O’Brien’s long term Australian study also 
reported similar revision rates of nearly 40% in the first 10 years after band placement 
[2728]. However, because of the evolution of band construction and operative technique, this 
had dropped to 6.4% over the last 5 years [2728]. 
The overall risks of all bariatric surgery itself are small, given the complex nature and co-
morbidity burden of the patients involved, with the composite complication rate of gastric 
bypass (3.4%), being similar to that of laparoscopic cholecystectomy or hysterectomy [3638]. 
However, the reporting of adverse events in the outcomes of clinical trials is highly variable 
[3739]. A 2014 systematic review of the risks of bariatric surgery indicated a cumulative 
lifetime complication rate of 17% and a reoperation rate of 7%, but there were significant 
differences between the techniques [3827]. Thus, there were more early complications with 
gastric bypass than gastric banding, but the overall re-operation rate for banding was higher 
(although this mainly related to minor reoperations to the subcutaneous access port) [19, 24-
2930]. Typically peri-operative complications occurred more frequently following gastric 
bypass than banding (8.0% vs 0.5%), while gastric bands had more long-term complications 
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13
requiring corrective procedures than gastric bypass (9% vs 2%). However, large volume 
gastric band units have shown that low re-operation rates, comparable overall to other 
procedures long term, are achievable [2728].  Thus, it may be that at a population level, this 
operation provides the greatest access to the benefits of weight loss surgery for the largest 
number of patients. 
In view of this, it is surprising that the proportion of patients in the UK having gastric banding 
has reduced over the last 5 years from 21% among NHS patients in 2009-10 to 14% in 
2011-13 [12, 13].  Several factors may account for this: the rise in popularity of the gastric 
sleeve operation (despite the paucity of long term data); the perceived difficulty with 
arranging optimal long-term care for patients; and peer pressure among patients due to the 
quicker weight loss attained with gastric bypass, even though weight loss at three years is 
comparable between all 3 operations.  In contrast, the proportion of self-funded patients 
having banding was 42% in 2011-13, suggesting that it still maintains sufficient popularity 
and attractiveness to patients, perhaps due to its affordability.  Patients also commonly 
perceive it as being less invasive than either gastric bypass or sleeve gastrectomy surgery, and 
indeed it is technically less invasive than these stapling operations.. 
Mortality rates  
The overall mortality rate for all primary bariatric surgery [12-14] is one tenth that of cardiac 
surgery and comparable to elective arthroscopy, with the risk of gastric banding reportedly 
being the lowest of the currently available surgical options (<0.01% vs 0.07% for gastric 
bypass) [12, 19, 26, 3840].  Long term there is reportedly survival benefit compared to no 
surgery for gastric banding patients [26, 2728]. 
Revisional bariatric surgery and re-operations for gastric banding 
Bariatric surgery prevents and treats disease and disability, and improves quality of life, but 
the need for reoperation (revisional surgery) reduces the clinical and cost effectiveness. In 
addition to operations for complications (as above), revisional surgery may be considered for 
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14
later weight regain. However, the cumulative burden of revisional surgery on the patient and 
healthcare systems may be substantial, and revision surgery to the same or another bariatric 
operation (not including minor reoperations on the subcutaneous band access port) carries a 
14 times increased mortality [12, 13, 3940].  
Weight regain after bariatric surgery is seen in a small but significant group of patients of all 
surgical techniques. Unfortunately it is not possible to predict before surgery which patients 
will fail to lose much weight or who will have later weight regain. A recent systematic review 
suggested multifactorial causes [4041], dietary, behavioural, physical, as well as surgical 
factors (in <20% of cases) which vary for the different techniques at different follow up times 
points.  Clearly, for gastric banding, intensive input from all members of the MDT, and 
frequent (monthly) follow-up intervals after surgery are particularly important in producing 
and maintaining weight-loss [41 42 - 4344]. As dietary, psychological and physical inactivity 
were the main factors in up to 80% of weight regain, addressing these requires a clinical 
service with a systematic approach to assess and identify those patients who may have a 
surgical factor for weight regain which might benefit from revisional surgery. Importantly, 
current data suggest that every patient who has had a gastric band removed, for any reason, 
will have weight regain back to or near their baseline level [4445].  
Cost effectiveness of gastric banding 
The long term benefits of bariatric surgery for weight loss, co-morbidity resolution, lower 
cancer rates and improved mortality could be expected to lead to a health care cost saving 
but results are not that clear cut. While a systematic review in 2011 [45][46] suggested that 
weight-loss surgery was cost effective compared to non-surgical treatment, a 2014 study on 
insurance provider claim costs after bariatric surgery showed no reduction in actual costs of 
claims [46]47]. However, the measure used for comparison is important, and many studies in 
different countries have shown that the incremental cost effectiveness ratio per quality- or 
disability- adjusted life year varied from about £1,300 for gastric banding in Australia [4847], 
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to £4,000 - £4,500 for all laparoscopic weight loss surgery in the USA [4948].  Interestingly, 
while all these values are far below the cost-effectiveness threshold for the respective 
countries (and also for the UK), gastric banding may be the most cost saving treatment at a 
population level. 
An analysis of data using a decision analytic model from the Scandinavian Registry, 
covering cardiovascular disease, diabetes and surgical complications, showed that bariatric 
surgery led to a cost saving when compared to non-surgical management of weight loss 
[5049]. When the risk reduction of vascular events, reduction in diabetes and gain in quality 
adjusted life years were extrapolated for the whole cohort, operated on in one year, the 
lifetime gains were over 32,000 quality-adjusted person years, and a net saving of £43 
million in health care costs. 
The very low volume of bariatric surgery in the UK represents much less than 1 in 100 of the 
5%, or 2.1 million people [5051], who meet UK NICE guidelines for surgery. In other 
developed countries as well there are large differences in the prevalence of co-morbidities 
and socio-demographic status between surgery-eligible patients and bariatric surgery 
recipients [5251]. Clearly no healthcare system could provide capacity to treat such a 
potentially great demand, but the overwhelming evidence is that surgery is clinically 
beneficial, and cost effective. Thus, the RCT evidence in the NICE Guidance showed clear 
improvement in every aspect of diabetes control and on this basis increasing availability of 
bariatric surgery should be a clear aspiration for healthcare services. Alternatively, the 
availability of government funded weight-loss surgery could be limited to the procedure with 
the lowest costs and shortest hospitalization requirements, to maximise the opportunity for 
delivery of a service. This strategy would favour gastric banding, although this does not take 
into account the longer term follow up costs, and the provision of services required, for gastric 
band adjustments in the community or specialised clinics. 
CONCLUSIONS 
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Obesity, with nearly 30 million sufferers in the UK currently, and its treatment, is a huge 
problem for the NHS. Current evidence shows that only bariatric surgery gives clinically 
meaningful weight loss, although there is a paucity of high quality long-term evidence. 
Despite its effectiveness less than 5,000 bariatric procedures were performed in the NHS in 
2013 [12, 13], thus the NHS provides the life-saving and quality of life improving benefit of 
surgery to less than 1 in 4,000 of the severely obese population in the UK. There would need 
to be a huge turn-around in obesity service provision for any significant population health 
gains to be achieved. The nature of which operation would best deliver these gains is still 
unknown, more high quality studies are needed, but with the lowest reported incremental 
cost effectiveness ratio per quality adjusted life year, gastric banding may provide the NHS 
with the most punch for its pound. However, unlike Australia, the UK NHS is not currently well 
set up to look after large number of gastric band patients and adjust the bands regularly in 
hospital (outside of clinical trials) or in the community. This issue of gastric band follow-up is 
probably the reason why many patients and surgeons do not choose gastric banding over other 
operations in the NHS. In addition, many bands are removed by surgeons in non-specialist 
centres if the patient develops a problem such as slippage, rather than having it rectified.  It 
would also require a shift in the moral perspective of delivering treatments effective at 
improving quality of life to those with a significant need [5253]. Still a major unknown 
remains the costs associated with the management of the long-term complications of 
bariatric surgery, including that of modern gastric banding, which appear comparable for all 
techniques. 
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ABSTRACT 
Background 
Obesity levels in the UK have reached a sustained high and about 5% of the population 
would be candidates for bariatric surgery based upon current UK NICE guidelines, which has 
important implications for Clinical Commissioning Groups. 
Sources of data 
Summary data from Cochrane systematic reviews, randomised controlled trials (RCTs) and 
cohort studies. 
Areas of agreement 
Currently the only treatment that offers significant and durable weight-loss for those with 
severe and complex obesity is surgery. Three operations account for 95% of all bariatric 
surgery in the UK, but the NHS offers surgery to only a small fraction of those who could 
benefit. Laparoscopic adjustable gastric banding (gastric banding) has potentially the lowest 
risk and up-front costs of the three procedures. 
Areas of controversy 
Reliable level 1 evidence of the relative effectiveness of the operations is lacking. 
Growing points 
As a point intervention, weight-loss surgery together with the chronic disease management 
strategy for obesity can prevent significant future disease and mortality, and the NHS should 
embrace both. 
Areas timely for developing research 
Better RCT evidence is needed including clinical effectiveness and economic analysis to 
answer the important question ‘which is the best of the three operations most frequently 
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performed?’  This review considers the current evidence for gastric banding for the treatment 
of severe and complex obesity. 
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5 
INTRODUCTION 
Obesity is a major worldwide public health problem with significant implications for primary 
care, particularly where obesity prevalence in developed countries is as high as 32.5% in 
women in high income North American countries, 29.8% in Australasia and 21.0% in 
Western Europe [1]. Although obesity levels may have reached a plateau, the burden of the 
important obesity related co-morbidities, such as type 2 diabetes, which was 382 million 
people worldwide in 2013, is predicted to rise to over 590 million in 2035 [2]. Both diabetes 
and obesity are independent risk factors for many important cancers [3, 4].  Obesity 
significantly increases many functional disorders and worsens overall health related quality 
of life [5], which can be improved by weight loss and metabolic surgery [6]. Overall, there is 
substantial evidence that obesity is a chronic disease that shortens life expectancy, even 
with the current best medical management of its co-morbidities [7]. 
Bariatric surgery is the only reproducibly effective treatment for severe and complex obesity 
[8, 9]. UK NICE guidelines provide clear guidance for the delivery of health-care and 
recommend that: bariatric surgery is the first line of treatment for those with a BMI of ≥50 in 
whom lifestyle interventions have failed; and those with a BMI ≥40, or ≥35 with severe 
obesity-related co-morbidities, should be offered bariatric surgery [10]. Weight-loss and 
metabolic surgery procedures are among the most commonly performed elective general 
surgical operations in the world, with over 350,000 performed in 2011, [11] but in 2013 in the 
UK, with government funded health care, only around 8,000 operations were performed [12, 
13], of which around 4,300 operations are recorded as being performed in the public sector 
[14]. 
Bariatric surgery is a young surgical speciality, with increasing numbers of cases being 
performed over a relatively short time frame [11], and there is a lack of high quality long term 
outcome data for the procedures. The most up-to-date, 2014, Cochrane collaboration 
systematic review of weight loss surgery in adults could only provide synthesizable evidence 
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6 
for 3 years of follow up, and commented that ‘the long-term effects of surgery remain 
unclear’ [8]. However this level 1 evidence for short and medium term results of surgery can 
be compared directly to results for non-surgical interventions, and combined with some long-
term cohort studies of bariatric surgery, albeit in smaller numbers, to show a pattern of long-
term benefits from surgery. Given the established long-term benefit it is important to have 
large scale, pragmatic randomised controlled surgical trials to evaluate different techniques, 
to include economic evaluations, to give us the answer as to what is the best operation [15]. 
Gastric banding and how it facilitates weight loss 
In the UK >99% of gastric band procedures are performed laparoscopically and patients 
typically spend ≤1 days in hospital with very few early complications [12, 13]. The operation 
induces and sustains weight loss by activating a satiety mechanism.Adding or removing fluid 
from the band achieves optimal filling. Food is not retained above the optimally adjusted 
band, i.e. not physically restricted, but briefly delayed food bolus transit through the band 
and the continuous pressure of the optimally filled band on the stomach wall produces both 
early satiety and a lack of appetite [16]. The effects of the band on oesophageal and proximal 
gastric function appears to activate a satiety signal, transmitted to CNS satiety centres via the 
vagus nerve, without physically restricting the meal size [16]. Figure 1 shows the position of a 
gastric band with a small “virtual” pouch of stomach below the gastro-oesophageal junction, 
above the final band position, held within gastro-gastro tunnelling sutures. Ideally patients 
are followed up every 1 – 3 months for the first two years by the bariatric multidisciplinary 
team (MDT), and then yearly in conjunction with GPs as part of a shared care model of 
chronic disease management (NICE CG189) [10].  
Patients require life-long follow up for optimal weight control and co-morbidity resolution for 
gastric banding to work, especially as nutritional issues or complications can occur at any 
point after surgery [17, 18]. Symptoms of reflux, regurgitation or vomiting and especially 
nocturnal aspiration or dysphagia should alert the primary care GP to possible 
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7 
complications. Abdominal pain along with any of these symptoms may suggest an acute 
complication, but other causes of abdominal pain should always be considered. Lifelong 
care involves essential counselling about food choices and eating patterns, as well as 
adjustment of the band [18]. Patients should therefore not be offered revisional surgery 
unless a process for continuing care is in place with the bariatric multidisciplinary team and 
within primary care.  
 
Figure 1 The adjustable gastric band. (Images reproduced from SM Griffin, SA Raimes, J 
Shenfine. Oesophagogastric Surgery. 5th ed. Saunders Elsevier, 2013) 
 
Weight loss effects of gastric bands & bariatric surgery 
The 2014 Cochrane review into weight loss surgery for adults included 22 randomised trials 
with 1,798 participants. The authors compared surgery with non-surgical interventions or 
different surgical procedures and most studies followed participants for only 12 to 36 months 
[8]. All of the trials which compared surgery with non-surgical interventions for weight loss 
found that surgery was significantly superior for weight loss at 1-2 years. This mirrored a 
2013 systematic review and meta-analysis that directly compared surgery and medical 
therapy, using 11 randomised studies with 796 included patients, and a random effect 
model, clearly favouring surgery [9]. With study follow up of up to 2 years individuals 
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8 
undergoing bariatric surgery lost more body weight (mean difference −26 kg (95% 
confidence interval −31 to −21), P<0.001) than those with medical therapy alone. 
In the Cochrane review no clinically significant differences between the three main 
techniques of gastric band, all types of gastric bypass or sleeve gastrectomy existed for the 
majority of time points within ‘multi-trial’ evidence. Although only three trials directly 
compared gastric banding with laparoscopic Roux-en-Y gastric bypass (gastric bypass), the 
latter produced greater weight loss, with a mean difference in body mass index (BMI) 
reduction up to five years of -5.2 kg/m² (95% confidence interval -6.4 to -4.0; P<0.00001). 
However, this was only from a total of 265 patients when combined, and the quality of the 
evidence was described as moderate at best. In the seven included trials of gastric bypass 
and sleeve gastrectomy there was no consistent picture as to which procedure was better or 
worse, but with a low quality of evid nce [8]. For the 2013 systematic review the cumulative 
body weight loss was similar but not statistically significantly different between gastric 
banding and gastric bypass or other techniques combined (mean difference between 6 and 
7 kg, P>0.20) [9]. Effects on co-morbidities, complications and additional surgical procedures 
were neutral for the three main procedures in these reviews [8, 9]. Similarly a large 
prospective database, the Michigan Bariatric Surgery Collaborative, concluded that there 
was comparable effectiveness of gastric banding, gastric bypass and sleeve gastrectomy for 
the treatment of severe obesity, when assessing weight-loss and complications in 3 matched 
groups of nearly 3,000 patients each over 3 years [19]. 
As the low quality of evidence in data synthesis studies is a recurrent issue, there still exists 
a need for long-term data from a well-conducted, methodologically sound, pragmatic, 
multicentre, randomised trial of gastric banding and other bariatric techniques.  Two on-
going trials surgical randomised trials are the Swiss Multi-centre Bypass or Sleeve Study 
[20] and the UK By-Band randomised controlled trial [15].  In 2015 the latter has been 
converted to a three-arm trial of gastric banding, gastric bypass and sleeve gastrectomy (By-
Band-Sleeve), and is the only such trial in the world comparing all three techniques. 
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9 
Importantly these trials both include outcomes of weight and quality of life as primary 
outcome measures, and will also provide secondary outcome data on weight related co-
morbidities and an economic evaluation of the study groups. 
Longer-term weight loss outcomes for gastric banding  
In the absence of well-conducted randomised trials with funded long-term data collection, 
long-term data of bariatric surgery are only available from observational studies and a few 
small, randomised trials. Most individual studies that quote >10 year data report that 
obstacles to follow-up impede the collection of accurate long-term data [21]. The longest 
follow up data is from the Swedish Obesity Study (SOS) [22], and has shown that bariatric 
surgery can reduce mortality, as well as cardiovascular and cancer risk over more than 10 
years, in matched groups of over 2,000 patients. While two thirds of the patients in the SOS 
studies had a procedure that is no longer considered first line for weight loss (vertical 
banded gastroplasty), the study includes gastric bands with the longest follow up data being 
up to 20 years. The SOS shows maintenance of weight loss (18% of total body weight) in the 
all surgery groups at this time point, compared to 1% weight loss in controls, with 
sustainable reduction in diabetes rates, cardiovascular and cancer risks [23]. 
The only randomised trial with long term results of 10 years compared a small cohort (n = 
51) of Italian patients randomised to gastric banding or gastric bypass [24]. The mean 
percent excess weight loss achieved at 10 years was 46 % ± 27 for gastric banding vs 69 % 
± 29 for gastric bypass. With a mean BMI of patients in the two groups of 44, this equals a 
total body weight loss of 19 - 27%, comparable to that seen in the SOS study. A larger (n = 
197) US randomised trial with 4 year follow up to 2007 measured similar excess weight loss 
outcomes with 45 ± 28% for gastric band vs 68 ± 19% for bypass in the medium-term but 
bypass was associated with more peri-operative and late complications and a higher early 
readmission rate [25]. A systematic review of randomised and prospective studies 
comparing gastric banding with gastric bypass, with more than 3-5 year follow up (29 studies 
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10
with 7971 patients), similarly showed that the mean sample size–weighted percentage of 
excess weight loss for gastric banding was 45.0% (n = 4109) vs 65.7% for gastric bypass (n 
= 3544) [26]. In all of these studies gastric band patients had a slower initial weight loss, 
which was typically maintained in the medium to long-term. In contrast, bypass patients lost 
weight rapidly in the first year and then started to regain some weight [23-26]. Additionally 
with gastric banding there is a proportion of patients, up to 15% who do not tolerate the band 
and fail to achieve any meaningful weight loss [27]. 
Gastric banding is the most predominant technique in Australia, and from there O’Brien et al 
have reported on 15-year follow up data from a large prospectively followed cohort of over 
3,200 patients. The reported mean percent excess weight loss data is similar, 47% at 10 
years (n = 714), and at 15 years (although in only 54 patients) [28]. This again equals 20.2% 
total body weight loss maintained at 10 - 15 years in the study population.   
Other long-term studies are ongoing, such as the US Longitudinal Assessment of Bariatric 
Surgery [29], which is prospectively following nearly 2,500 patients after weight loss surgery, 
one quarter of whom had a gastric band. Three-year results published so far suggest 
average weight loss of 16% total body weight for those undergoing a gastric band, with most 
of the weight loss coming in the first year for all patients. However compared to gastric 
bypass patients (who started to regain some weight) the trajectory of weight change in the 
gastric banding group was maintained. In summary, all of the studies with at least 10 year 
follow up suggest that a clinically significant total body weight loss of 16 – 20 % is 
maintained in the long term following bariatric surgery, including gastric banding. 
Diabetic outcomes with gastric banding 
Diabetes patients are an important group of those undergoing bariatric surgery, accounting 
for nearly one third of UK NHS bariatric patients [12, 13], and they have potentially the 
greatest benefits with a reduction in long-term diabetic complications.  Early studies into 
bariatric surgery suggested that four fifths of all diabetic bariatric patients had a ‘resolution’ 
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11
of diabetes at 2 years following surgery [30]. However a 2014 meta-analysis of longer term 
effects of metabolic surgery for type 2 diabetes, with stricter definitions for remission, 
reported a 65% remission rate and 89% remission or improvement rate in studies with more 
than 2 years follow up [31]. The large UK national registry of bariatric surgery showed a 60 – 
70% improvement in all diabetic patients at 3 years following surgery, with a decrease in 
medication use [12, 13]. 
A systematic review in 2012 of 35 studies involving gastric banding to treat diabetes showed 
remission or improvement in diabetes from 53% to 70% over 2 years, and although there 
was considerable heterogeneity in study quality the authors concluded that clinically relevant 
improvements in diabetes outcomes occurred in obese people with type 2 diabetes following 
LAGB surgery [32]. The only randomised trial included in this review by Dixon et al, consldered 
that participants randomized to surgical therapy were more likely to achieve remission of type 2 
diabetes through greater weight loss [33]. The 2014 systematic review of studies comparing 
gastric banding with gastric bypass, included nine studies which measured co-morbidity 
improvement, and for type 2 diabetes (glycated haemoglobin <6.5% without medication), 
sample-size–weighted remission rates were 28.6% for gastric band (n = 96) and 66.7% for 
gastric bypass (n = 428) [26].  
The interim analysis to assess the early control of type 2 diabetes (T2D), 1 year after gastric 
banding in the 5-year, prospective, observational Helping Evaluate Reduction in Obesity 
(HERO) study (N = 1,106) showed 72% achieved target control of diabetes compared with 
42% at baseline [34]. It is important to note that in these band studies, and many other 
studies of bariatric surgery, patients with shorter disease duration and not yet on insulin have 
the best likelihood of control of diabetes [12, 24, 31-34]. Others have even performed studies 
of gastric banding in patients with lower BMIs and shown that remission of diabetes can be 
achieved in 50% of patients [35]. Reflecting similar studies of all bariatric surgery in diabetics 
the 2014 UK NICE guidelines reduced the BMI threshold to 30 for ‘newly diagnosed 
diabetics’ to access bariatric surgery [10]. 
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12
 
Bariatric surgery can also aid diabetes prevention. In an analysis of SOS patients without 
diabetes (n = 3,429) and a BMI of 34 – 38 at the start, after 15 years the incident rates of 
diabetes was 28.4 per 1,000 in the controls but only 6.8 per 1,000 in those who had surgery 
[36]. 
Complication rates  
The major complications of gastric banding requiring re-operation or removal, are infection of 
the band, slippage and erosion, plus a group of patients who have intolerance of the band 
and fail to achieve any meaningful weight loss. For complications, the large systematic 
reviews of weight-loss surgery report reoperation rates as high as 40% [8, 9], but this 
includes some very early studies. Indeed, studies of bands placed pre-2000 reported rates of 
reoperation or removal as high as 60% [37], and O’Brien’s long term Australian study also 
reported similar revision rates of nearly 40% in the first 10 years after band placement [28]. 
However, because of the evolution of band construction and operative technique, this had 
dropped to 6.4% over the last 5 years [28]. 
The overall risks of all bariatric surgery itself are small, given the complex nature and co-
morbidity burden of the patients involved, with the composite complication rate of gastric 
bypass (3.4%), being similar to that of laparoscopic cholecystectomy or hysterectomy [38]. 
However, the reporting of adverse events in the outcomes of clinical trials is highly variable 
[39]. A 2014 systematic review of the risks of bariatric surgery indicated a cumulative lifetime 
complication rate of 17% and a reoperation rate of 7%, but there were significant differences 
between the techniques [27]. Thus, there were more early complications with gastric bypass 
than gastric banding, but the overall re-operation rate for banding was higher (although this 
mainly related to minor reoperations to the subcutaneous access port) [19, 24-30]. Typically 
peri-operative complications occurred more frequently following gastric bypass than banding 
(8.0% vs 0.5%), while gastric bands had more long-term complications requiring corrective 
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13
procedures than gastric bypass (9% vs 2%). However, large volume gastric band units have 
shown that low re-operation rates, comparable overall to other procedures long term, are 
achievable [28].  Thus, it may be that at a population level, this operation provides the 
greatest access to the benefits of weight loss surgery for the largest number of patients. 
In view of this, it is surprising that the proportion of patients in the UK having gastric banding 
has reduced over the last 5 years from 21% among NHS patients in 2009-10 to 14% in 
2011-13 [12, 13].  Several factors may account for this: the rise in popularity of the gastric 
sleeve operation (despite the paucity of long term data); the perceived difficulty with 
arranging optimal long-term care for patients; and peer pressure among patients due to the 
quicker weight loss attained with gastric bypass, even though weight loss at three years is 
comparable between all 3 operations.  In contrast, the proportion of self-funded patients 
having banding was 42% in 2011-13, suggesting that it still maintains sufficient popularity 
and attractiveness to patients, perhaps due to its affordability.  Patients also commonly 
perceive it as being less invasive than either gastric bypass or sleeve gastrectomy surgery, and 
indeed it is technically less invasive than these stapling operations. 
Mortality rates  
The overall mortality rate for all primary bariatric surgery [12-14] is one tenth that of cardiac 
surgery and comparable to elective arthroscopy, with the risk of gastric banding reportedly 
being the lowest of the currently available surgical options (<0.01% vs 0.07% for gastric 
bypass) [12, 19, 26, 40].  Long term there is reportedly survival benefit compared to no 
surgery for gastric banding patients [26, 28]. 
Revisional bariatric surgery and re-operations for gastric banding 
Bariatric surgery prevents and treats disease and disability, and improves quality of life, but 
the need for reoperation (revisional surgery) reduces the clinical and cost effectiveness. In 
addition to operations for complications (as above), revisional surgery may be considered for 
later weight regain. However, the cumulative burden of revisional surgery on the patient and 
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14
healthcare systems may be substantial, and revision surgery to the same or another bariatric 
operation (not including minor reoperations on the subcutaneous band access port) carries a 
14 times increased mortality [12, 13, 40].  
Weight regain after bariatric surgery is seen in a small but significant group of patients of all 
surgical techniques. Unfortunately it is not possible to predict before surgery which patients 
will fail to lose much weight or who will have later weight regain. A recent systematic review 
suggested multifactorial causes [41], dietary, behavioural, physical, as well as surgical 
factors (in <20% of cases) which vary for the different techniques at different follow up times 
points.  Clearly, for gastric banding, intensive input from all members of the MDT, and 
frequent (monthly) follow-up intervals after surgery are particularly important in producing 
and maintaining weight-loss [42 - 44]. As dietary, psychological and physical inactivity were 
the main factors in up to 80% of weight regain, addressing these requires a clinical service 
with a systematic approach to assess and identify those patients who may have a surgical 
factor for weight regain which might benefit from revisional surgery. Importantly, current data 
suggest that every patient who has had a gastric band removed, for any reason, will have 
weight regain back to or near their baseline level [45].  
Cost effectiveness of gastric banding 
The long term benefits of bariatric surgery for weight loss, co-morbidity resolution, lower 
cancer rates and improved mortality could be expected to lead to a health care cost saving 
but results are not that clear cut. While a systematic review in 2011 [46] suggested that 
weight-loss surgery was cost effective compared to non-surgical treatment, a 2014 study on 
insurance provider claim costs after bariatric surgery showed no reduction in actual costs of 
claims 47]. However, the measure used for comparison is important, and many studies in 
different countries have shown that the incremental cost effectiveness ratio per quality- or 
disability- adjusted life year varied from about £1,300 for gastric banding in Australia [48, to 
£4,000 - £4,500 for all laparoscopic weight loss surgery in the USA [49].  Interestingly, while 
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15
all these values are far below the cost-effectiveness threshold for the respective countries 
(and also for the UK), gastric banding may be the most cost saving treatment at a population 
level. 
An analysis of data using a decision analytic model from the Scandinavian Registry, 
covering cardiovascular disease, diabetes and surgical complications, showed that bariatric 
surgery led to a cost saving when compared to non-surgical management of weight loss [50. 
When the risk reduction of vascular events, reduction in diabetes and gain in quality adjusted 
life years were extrapolated for the whole cohort, operated on in one year, the lifetime gains 
were over 32,000 quality-adjusted person years, and a net saving of £43 million in health 
care costs. 
The very low volume of bariatric surgery in the UK represents much less than 1 in 100 of the 
5%, or 2.1 million people [51], who meet UK NICE guidelines for surgery. In other developed 
countries there are large differences in the prevalence of co-morbidities and socio-
demographic status between surgery-eligible patients and bariatric surgery recipients [52. 
Clearly no healthcare system could provide capacity to treat such a potentially great 
demand, but the overwhelming evidence is that surgery is clinically beneficial, and cost 
effective. Thus, the RCT evidence in the NICE Guidance showed clear improvement in every 
aspect of diabetes control and on this basis increasing availability of bariatric surgery should 
be a clear aspiration for healthcare services. Alternatively, the availability of government 
funded weight-loss surgery could be limited to the procedure with the lowest costs and 
shortest hospitalization requirements, to maximise the opportunity for delivery of a service. 
This strategy would favour gastric banding, although this does not take into account the longer 
term follow up costs, and the provision of services required, for gastric band adjustments in the 
community or specialised clinics. 
CONCLUSIONS 
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Obesity, with nearly 30 million sufferers in the UK currently, and its treatment, is a huge 
problem for the NHS. Current evidence shows that only bariatric surgery gives clinically 
meaningful weight loss, although there is a paucity of high quality long-term evidence. 
Despite its effectiveness less than 5,000 bariatric procedures were performed in the NHS in 
2013 [12, 13], thus the NHS provides the life-saving and quality of life improving benefit of 
surgery to less than 1 in 4,000 of the severely obese population in the UK. There would need 
to be a huge turn-around in obesity service provision for any significant population health 
gains to be achieved. The nature of which operation would best deliver these gains is still 
unknown, more high quality studies are needed, but with the lowest reported incremental 
cost effectiveness ratio per quality adjusted life year, gastric banding may provide the NHS 
with the most punch for its pound. However, unlike Australia, the UK NHS is not currently well 
set up to look after large number of gastric band patients and adjust the bands regularly in 
hospital (outside of clinical trials) or in the community. This issue of gastric band follow-up is 
probably the reason why many patients and surgeons do not choose gastric banding over other 
operations in the NHS. In addition, many bands are removed by surgeons in non-specialist 
centres if the patient develops a problem such as slippage, rather than having it rectified.  It 
would also require a shift in the moral perspective of delivering treatments effective at 
improving quality of life to those with a significant need [53]. Still a major unknown remains 
the costs associated with the management of the long-term complications of bariatric 
surgery, including that of modern gastric banding, which appear comparable for all 
techniques. 
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